EP2044091A4 - Compounds for the treatment of periodontal disease - Google Patents
Compounds for the treatment of periodontal diseaseInfo
- Publication number
- EP2044091A4 EP2044091A4 EP07812123A EP07812123A EP2044091A4 EP 2044091 A4 EP2044091 A4 EP 2044091A4 EP 07812123 A EP07812123 A EP 07812123A EP 07812123 A EP07812123 A EP 07812123A EP 2044091 A4 EP2044091 A4 EP 2044091A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- compounds
- treatment
- periodontal disease
- periodontal
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80450406P | 2006-06-12 | 2006-06-12 | |
US82389306P | 2006-08-29 | 2006-08-29 | |
PCT/US2007/071049 WO2007146965A2 (en) | 2006-06-12 | 2007-06-12 | Compounds for the treatment of periodontal disease |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2044091A2 EP2044091A2 (en) | 2009-04-08 |
EP2044091A4 true EP2044091A4 (en) | 2010-08-04 |
Family
ID=38832802
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP07812123A Withdrawn EP2044091A4 (en) | 2006-06-12 | 2007-06-12 | Compounds for the treatment of periodontal disease |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP2044091A4 (en) |
KR (1) | KR20090029797A (en) |
AU (1) | AU2007257689A1 (en) |
BR (1) | BRPI0713010A2 (en) |
CA (1) | CA2654449A1 (en) |
IL (1) | IL195571A0 (en) |
MX (1) | MX2008015918A (en) |
RU (1) | RU2008152367A (en) |
WO (1) | WO2007146965A2 (en) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2540966T3 (en) | 2005-02-16 | 2015-07-15 | Anacor Pharmaceuticals, Inc. | Boronoftalide biocide compounds |
BRPI0621279B1 (en) | 2005-12-30 | 2021-07-20 | Anacor Pharmaceuticals, Inc | SMALL BORON CONTAINING MOLECULES |
DK2719388T3 (en) | 2006-02-16 | 2019-05-13 | Anacor Pharmaceuticals Inc | Boron-containing small molecules as anti-inflammatory agents |
JO3598B1 (en) | 2006-10-10 | 2020-07-05 | Infinity Discovery Inc | Boronic acids and esters as inhibitors of fatty acid amide hydrolase |
JO3396B1 (en) | 2007-06-20 | 2019-10-20 | Anacor Pharmaceuticals Inc | Boron-containing small molecules |
EP3246034A1 (en) | 2008-03-06 | 2017-11-22 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as anti-inflammatory agents |
EP2282742A1 (en) * | 2008-04-09 | 2011-02-16 | Infinity Pharmaceuticals, Inc. | Inhibitors of fatty acid amide hydrolase |
US8853424B2 (en) | 2008-08-11 | 2014-10-07 | Japan Science And Technology Agency | Protein cross-linking inhibitor |
US8461336B2 (en) | 2008-09-04 | 2013-06-11 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
WO2010027975A1 (en) | 2008-09-04 | 2010-03-11 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
US9493489B2 (en) | 2008-10-15 | 2016-11-15 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as anti-protozoal agents |
JP2012512262A (en) | 2008-12-17 | 2012-05-31 | アナコール ファーマシューティカルズ,インコーポレーテッド | Polymorph of (S) -3-aminomethyl-7- (3-hydroxy-propoxy) -3H-benzo [C] [1,2] oxaborol-1-ol |
CA2757622A1 (en) | 2009-04-07 | 2010-10-14 | Infinity Pharmaceuticals, Inc. | Inhibitors of fatty acid amide hydrolase |
WO2010118155A1 (en) | 2009-04-07 | 2010-10-14 | Infinity Pharmaceuticals, Inc. | Inhibitors of fatty acid amide hydrolase |
TW201110996A (en) * | 2009-06-03 | 2011-04-01 | Colgate Palmolive Co | Borinic compositions |
US8343944B2 (en) | 2009-07-28 | 2013-01-01 | Anacor Pharmaceuticals, Inc. | Trisubstituted boron-containing molecules |
WO2011019618A1 (en) | 2009-08-14 | 2011-02-17 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as antiprotozoal agents |
WO2011049971A1 (en) | 2009-10-20 | 2011-04-28 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as antiprotozoal agents |
WO2011060199A1 (en) | 2009-11-11 | 2011-05-19 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
WO2011063293A1 (en) * | 2009-11-20 | 2011-05-26 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as antihelminth agents |
RU2414210C1 (en) * | 2009-12-28 | 2011-03-20 | Общество С Ограниченной Ответственностью "Сплат-Косметика" (Ооо "Сплат-Косметика") | Medication for removal of tobacco resins and based on it composition |
WO2011094450A1 (en) | 2010-01-27 | 2011-08-04 | Anacor Pharmaceuticals, Inc | Boron-containing small molecules |
MX336742B (en) | 2010-02-03 | 2016-01-29 | Infinity Pharmaceuticals Inc | Fatty acid amide hydrolase inhibitors. |
WO2011116348A1 (en) | 2010-03-19 | 2011-09-22 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as anti-protozoal agent |
DK2613788T3 (en) | 2010-09-07 | 2017-08-07 | Anacor Pharmaceuticals Inc | BENZOXABOROLD DERIVATIVES FOR TREATMENT OF BACTERIA INFECTIONS |
AR088668A1 (en) * | 2011-11-21 | 2014-06-25 | Lilly Co Eli | SMALL MOLECULES CONTAINING BORO |
US11039617B2 (en) | 2013-01-30 | 2021-06-22 | Agrofresh Inc. | Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness |
CA2899317A1 (en) | 2013-01-30 | 2014-08-07 | Dow Agrosciences Llc | Use of benzoxaboroles as volatile antimicrobial agents on meats, plants, or plant parts |
US8669207B1 (en) | 2013-01-30 | 2014-03-11 | Dow Agrosciences, Llc. | Compounds and compositions |
US9585396B2 (en) | 2013-01-30 | 2017-03-07 | Agrofresh Inc. | Volatile applications against pathogens |
US10070649B2 (en) | 2013-01-30 | 2018-09-11 | Agrofresh Inc. | Volatile applications against pathogens |
CA2953881A1 (en) | 2014-07-01 | 2016-01-07 | Daiichi Sankyo Company, Limited | Tricyclic benzoxaboroles as antibacterial agents |
EP3426029B1 (en) | 2016-03-07 | 2023-08-30 | AgroFresh Inc. | Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops |
US11447506B2 (en) | 2016-05-09 | 2022-09-20 | Anacor Pharmaceuticals, Inc. | Crystal forms of crisaborole in free form and preparation method and use thereof |
BR112018073017B1 (en) * | 2016-05-09 | 2022-06-14 | Anacor Pharmaceuticals, Inc | CRYSTALLINE FORM I OF CHRYSABOROLE IN FREE FORM, METHOD OF PREPARATION AND USE |
CN107759625B (en) * | 2016-08-22 | 2020-12-29 | 药源药物化学(上海)有限公司 | Preparation method of 4- (1-hydroxy-1, 3-dihydrobenzo [ c ] [1,2] oxaborole-5-yloxy) benzonitrile |
US10961261B2 (en) | 2017-03-01 | 2021-03-30 | Anacor Pharmaceuticals, Inc. | Oxaborole analogs and uses thereof |
US10973835B2 (en) * | 2017-03-09 | 2021-04-13 | The Penn State Research Foundation | Boron-containing small molecules for inhibiting activity of a receptor-like protein tyrosine phosphatase |
CN110183477B (en) * | 2019-07-03 | 2022-03-04 | 石家庄诚志永华显示材料有限公司 | Organic electroluminescent compounds and use thereof |
US20230340530A1 (en) | 2020-08-31 | 2023-10-26 | Pfizer Inc. | Methods of Protecting RNA |
KR102638321B1 (en) * | 2022-01-27 | 2024-02-19 | 마이크로바이오헬스케어 주식회사 | Novel compound with anti-biofilm formation activity and use of the same |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1155698A1 (en) * | 1999-01-29 | 2001-11-21 | Nitto Kasei Co., Ltd. | Organoboron compounds exhibiting anticoccidial activities |
WO2004056322A2 (en) * | 2002-12-18 | 2004-07-08 | Anacor Pharmaceuticals, Inc. | Antibiotics containing borinic acid complexes and methods of use |
WO2005021559A2 (en) * | 2003-09-02 | 2005-03-10 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Oxazaborolidines as bacteria effectors |
WO2005123095A1 (en) * | 2004-06-14 | 2005-12-29 | Anacor Pharmaceuticals, Inc. | Anti-parasitic uses of borinic acid complexes |
WO2005123094A2 (en) * | 2004-06-14 | 2005-12-29 | Anacor Pharmaceuticals, Inc. | Treatment or prevention of skin conditions or tissue conditions in animals using boryloxypyridylmethanones |
WO2006007384A2 (en) * | 2004-06-14 | 2006-01-19 | Anacor Pharmaceuticals, Inc. | Antibiotics containing borinic acid complexes and methods of use |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4716035A (en) * | 1985-05-24 | 1987-12-29 | The Procter & Gamble Company | Oral compositions and methods for treating gingivitis |
-
2007
- 2007-06-12 KR KR1020097000565A patent/KR20090029797A/en not_active Application Discontinuation
- 2007-06-12 WO PCT/US2007/071049 patent/WO2007146965A2/en active Search and Examination
- 2007-06-12 BR BRPI0713010-4A patent/BRPI0713010A2/en not_active IP Right Cessation
- 2007-06-12 EP EP07812123A patent/EP2044091A4/en not_active Withdrawn
- 2007-06-12 CA CA002654449A patent/CA2654449A1/en not_active Abandoned
- 2007-06-12 AU AU2007257689A patent/AU2007257689A1/en not_active Abandoned
- 2007-06-12 MX MX2008015918A patent/MX2008015918A/en unknown
- 2007-06-12 RU RU2008152367/15A patent/RU2008152367A/en not_active Application Discontinuation
-
2008
- 2008-11-27 IL IL195571A patent/IL195571A0/en unknown
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1155698A1 (en) * | 1999-01-29 | 2001-11-21 | Nitto Kasei Co., Ltd. | Organoboron compounds exhibiting anticoccidial activities |
WO2004056322A2 (en) * | 2002-12-18 | 2004-07-08 | Anacor Pharmaceuticals, Inc. | Antibiotics containing borinic acid complexes and methods of use |
WO2005021559A2 (en) * | 2003-09-02 | 2005-03-10 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Oxazaborolidines as bacteria effectors |
WO2005123095A1 (en) * | 2004-06-14 | 2005-12-29 | Anacor Pharmaceuticals, Inc. | Anti-parasitic uses of borinic acid complexes |
WO2005123094A2 (en) * | 2004-06-14 | 2005-12-29 | Anacor Pharmaceuticals, Inc. | Treatment or prevention of skin conditions or tissue conditions in animals using boryloxypyridylmethanones |
US20060009422A1 (en) * | 2004-06-14 | 2006-01-12 | David Perry | Boron-containing compounds and methods of use |
WO2006007384A2 (en) * | 2004-06-14 | 2006-01-19 | Anacor Pharmaceuticals, Inc. | Antibiotics containing borinic acid complexes and methods of use |
Also Published As
Publication number | Publication date |
---|---|
IL195571A0 (en) | 2009-09-01 |
AU2007257689A1 (en) | 2007-12-21 |
WO2007146965A3 (en) | 2008-12-04 |
MX2008015918A (en) | 2009-01-14 |
CA2654449A1 (en) | 2007-12-21 |
WO2007146965A2 (en) | 2007-12-21 |
RU2008152367A (en) | 2010-07-20 |
KR20090029797A (en) | 2009-03-23 |
BRPI0713010A2 (en) | 2012-10-09 |
EP2044091A2 (en) | 2009-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL195571A0 (en) | Compounds for the treatment of periodontal disease | |
ZA200808178B (en) | Imidazolothiazole compounds for the treatment of disease | |
GB0610680D0 (en) | Therapeutic compounds | |
IL193678A0 (en) | Therapeutic compounds | |
GB0818175D0 (en) | Alkoxy compounds for disease treatment | |
GB0603041D0 (en) | Therapeutic compounds | |
HK1203925A1 (en) | Therapeutic compounds | |
GB0606663D0 (en) | Therapeutic compounds | |
GB0615809D0 (en) | Therapeutic compounds | |
GB0612971D0 (en) | Therapeutic compounds | |
GB0625349D0 (en) | Therapeutic compounds | |
HU0500145D0 (en) | Composition for the treatment of oral diseases | |
EP2079704A4 (en) | Therapeutic compounds | |
GB0625345D0 (en) | Therapeutic compounds | |
GB0400802D0 (en) | Compounds for the treatment of disease | |
GB0605573D0 (en) | Therapeutic Compounds | |
GB0603455D0 (en) | Therapeutic compounds | |
ZA200606780B (en) | Compounds for the treatment of diseases | |
GB0608269D0 (en) | Therapeutic compounds | |
GB2439923B (en) | Therapeutic compounds | |
GB0415352D0 (en) | Compounds for the treatment of disease | |
AU2007907021A0 (en) | Antibodies for the treatment of periodontal disease | |
GB0420867D0 (en) | Compounds for the treatment of diseases | |
GB0425073D0 (en) | Compounds for the treatment of diseases | |
IL177531A0 (en) | Compounds for the treatment of diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20090109 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA HR MK RS |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: ANACOR PHARMACEUTICALS, INC. |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61Q 11/00 20060101ALI20090519BHEP Ipc: A61K 31/69 20060101ALI20090519BHEP Ipc: C07F 5/05 20060101ALI20090519BHEP Ipc: C07F 5/02 20060101ALI20090519BHEP Ipc: C07F 5/00 20060101AFI20090519BHEP |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1129680 Country of ref document: HK |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20100706 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20110208 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1129680 Country of ref document: HK |